Ajanta Pharma Buyback 2020 Review – Record Date, Price, and Details

Must read

Daily Analysis of Stock Market – NIFTY – 24th November 2020

On Tuesday, The market had a gap up opening and remained in green for the whole session. At the closing, the market closed in...

NSE Revokes Karvy Stock Broking’s Membership

The National Stock Exchange (NSE) has declared Karvy Stock Broking Ltd as defaulter and has revoked the membership effective from Monday Market Closing."All members...

Buy Aurobindo Pharma With Target Of Rs 980: Motilal Oswal

Motilal Oswal has recommended a BUY on Aurobindo Pharma with a Target Price of Rs. 980, and an upside of 17% from CMP of Rs. 839.Aurobindo...

Daily Analysis of Stock Market – NIFTY – 23rd November 2020

On Monday, The market had a gap up opening, Later it slipped but closed in the green. At the closing, the market closed in...

Ajanta Pharma is engaged in the Business of Pharmaceutical products. Their business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA, and Institution sales. Soon after this, Gland Pharma IPO is launched, which is said to be the biggest Pharma IPO in India.

Advertisement

The board also decided to give another good news of Ajanta Pharma Buyback 2020 at a price of Rs. 1850 per share, where the price of Ajanta Pharma on 4th November closing was Rs. 1620, that’s almost at the premium of 15%.

Ajanta Pharma plans to purchase 7.35 lakh shares via Buyback at Rs. 1850 per equity share for an aggregate amount not exceeding Rs. 135 crores.

Ajanta Pharma Buyback 2020 Details & Review

Buyback TypeTender offer
Buyback Offer Amount:Rs. 135 Crores
Date of Board Meeting Approval3rd November 2020
Date of Public Announcement3rd November 2020
Buyback Offer Size0.84 %
Buyback Number of Shares7,35,000 Shares
Face Value2
Buyback PriceRs. 1850 Per Equity Share

Ajanta Pharma Buyback 2020 Dates

HPCL Buyback Record Date13th November 2020
Opening Date
Closing Date
Obligation (Fund Payout)
Settlement Date (Shares Payout)
Offer PriceRs. 1850/- per share

Ajanta Pharma Buyback 2020 Acceptance Ratio

Buy 54 Shares at CMP of Rs. 1620 ( 1,00,000/1850 = 54)

Acceptance RatioTotal Shares AcceptedBuyback PriceInvestment Amt
@ Rs 187 / Share
ProfitProfit%
20%1018508748023002.62%
40%2118508748048305.52%
60%3218508748073608.41%
80%43185087480989011.30%
100%541850874801242014.19%

Profit and all other calculations is done on the basis of price on 4nd November, 2020 i.e. Rs. 1620

Ajanta Pharma Financial Report

NarrationMar-15Mar-16Mar-17Mar-18Mar-19Mar-20
Sales 1,473.56   1,749.37 1,983.26            2,125.76            2,055.37 2,587.87
Expenses               969.34               1,160.84            1,292.49            1,467.36            1,488.71 1,904.44
Operating Profit               504.22    588.53    690.77               658.40               566.66 683.43
Other Income     9.35   19.68  19.9724.1520.85  88.17
Depreciation51.6444.43  61.21  59.5972.0895.72
Interest5.92    4.89 1.360.41     1.1611.91
Profit before tax               456.01558.89648.17 622.55514.27 663.97
Tax               146.15 143.28141.34153.91 127.30 196.27
Net profit               309.86 415.61   506.83468.64  386.97467.70
EPS35.25 47.2357.59    53.25 44.33   53.57
Price to earning34.8629.84 30.57  26.1123.3525.50
Price            1,229.001,409.151,760.551,390.351,035.201,366.30

Ajanta Pharma Buyback FAQs

What is Ajanta Pharma Buyback Price?

The company has fixed the Ajanta Pharma Buyback price at Rs. 1850.

What is the Ajanta Pharma Buyback 2020 Record Date?

The company has announced 13th November 2020 as the Record Date

- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Daily Analysis of Stock Market – NIFTY – 24th November 2020

On Tuesday, The market had a gap up opening and remained in green for the whole session. At the closing, the market closed in...

NSE Revokes Karvy Stock Broking’s Membership

The National Stock Exchange (NSE) has declared Karvy Stock Broking Ltd as defaulter and has revoked the membership effective from Monday Market Closing."All members...

Buy Aurobindo Pharma With Target Of Rs 980: Motilal Oswal

Motilal Oswal has recommended a BUY on Aurobindo Pharma with a Target Price of Rs. 980, and an upside of 17% from CMP of Rs. 839.Aurobindo...

Daily Analysis of Stock Market – NIFTY – 23rd November 2020

On Monday, The market had a gap up opening, Later it slipped but closed in the green. At the closing, the market closed in...

Hatsun Agro Product To Receive Subsidies From Government of Telangana Up To Rs. 25 Crores

Hatsun Agro Products which have its headquarter in Chennai is the fastest-growing Asian Dairy Company. It was founded by Ganesan father of R. G....